Vol. 14 No. 2 (2013)
Case Report

An Unusual Case of Resistant Hepatic Hydrothorax Treated with Octreotide Infusion

Published 2020-08-05

Keywords

  • Transjugular Intrahepatic Portosystemic Shunt,
  • Tissue Plasminogen Activator

How to Cite

1.
Ghahremani-Ghajar, M, Tabassomi M, Harada S, Vempilly JJ. An Unusual Case of Resistant Hepatic Hydrothorax Treated with Octreotide Infusion. McGill J Med [Internet]. 2020 Aug. 5 [cited 2025 Oct. 5];14(2). Available from: https://mjm.mcgill.ca/article/view/201

Abstract

Hepatic hydrothorax is an uncommon clinical problem observed in
patients with end stage liver disease and portal hypertension. The pathogenesis of pleural effusion in this condition is thought to involve the movement of ascitic fuid across diaphragmatic defects into pleural cavity facilitated by a negative pleural pressure. Therefore, tube thoracostomy is not considered to be a defnitive treatment option in the management of hepatic hydrothorax. We present a case of massive pleural effusion secondary to hepatic hydrothorax not responding to conventional treatment successfully treated with intravenous infusion of octreotide.

Downloads

Download data is not yet available.